On October 2, according to Reuters, two sources said that Eli Lilly was asked by the US government to increase insulin production; Pfizer was asked to increase production of its best-selling anti-cancer drug Aiboxin and cholesterol-lowering drug Lipitor; and London-based AstraZeneca was asked to consider moving its new headquarters to the United States. Two people familiar with the matter said that pharmaceutical industry executives receive almost daily calls from White House staff and senior of...